...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity
【24h】

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity

机译:产生先天性IL-13的核细胞在过敏性肺部炎症期间出现,并导致气道高反应性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: IL-4, IL-5, and IL-13 are thought to be central to the allergic asthmatic response. Previous work supposed that the essential source of these cytokines was CD4 + T H2 cells. However, more recent studies have suggested that other innate production of type 2 cytokines might be as important. Objectives: Nuocytes are a novel population of IL-13-producing innate cells, which are critical for protective immunity in Nippostrongylus brasiliensis infection. Given this, we investigated the potential existence and functional importance of nuocytes in experimental allergic asthma. Methods: We generated Il4 +/eGFPIl13 +/Tomato dual-reporter mice to study cytokine-producing cells during allergic inflammation. We adoptively transferred innate IL-13-producing cells to investigate their role in airways hyperreactivity (AHR). Results: We show that allergen-induced nuocytes infiltrate the lung and are a major innate source of IL-13. CD4 + T cells in the lung almost exclusively express only IL-13, whereas IL-4-producing T cells were restricted to the draining lymph nodes. Intranasal administration of IL-25 or IL-33 induced IL-13-producing nuocytes in the BAL fluid. Strikingly, adoptive transfer of wild-type nuocytes, but not Il13 -/- nuocytes, into Il13 -/- mice, which are normally resistant to IL-25-induced AHR, restored airways resistance and lung cell infiltration. Conclusions: These findings identify nuocytes as a novel cell type in allergic lung inflammation and an innate source of IL-13 that can directly induce AHR in the absence of IL-13-producing CD4 + T cells. These data highlight nuocytes as an important new consideration in the development of future allergic asthma therapy.
机译:背景:IL-4,IL-5和IL-13被认为是过敏性哮喘反应的关键。先前的工作认为这些细胞因子的重要来源是CD4 + T H2细胞。但是,最近的研究表明,其他先天产生的2型细胞因子可能同样重要。目的:核细胞是一种新的产生IL-13的先天性细胞群,对于巴西柔毛夜蛾感染中的保护性免疫至关重要。鉴于此,我们调查了实验性过敏性哮喘中核细胞的潜在存在和功能重要性。方法:我们产生了Il4 + / eGFPIl13 + / Tomato双重报告小鼠,研究变应性炎症过程中产生细胞因子的细胞。我们采用过继转移的天然产生IL-13的细胞来研究其在气道高反应性(AHR)中的作用。结果:我们显示,变应原诱导的核细胞浸润到肺中,并且是IL-13的主要先天来源。肺中的CD4 + T细胞几乎只表达IL-13,而产生IL-4的T细胞仅局限于引流淋巴结。经鼻内注射IL-25或IL-33可诱导BAL液中产生IL-13的核细胞。令人惊讶的是,野生型核细胞而不是Il13-/-核细胞的过继转移进入通常对IL-25诱导的AHR有抗性的Il13-/-小鼠恢复了呼吸道抗性和肺细胞浸润。结论:这些发现确定了核细胞是过敏性肺部炎症的一种新型细胞类型,并且是在没有产生IL-13的CD4 + T细胞的情况下可以直接诱导AHR的IL-13的先天来源。这些数据强调了核细胞是未来过敏性哮喘治疗发展中的重要新考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号